We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck’s Keytruda Delivers Positive Results in Untreated Metastatic NSCLC
Merck’s Keytruda Delivers Positive Results in Untreated Metastatic NSCLC
Merck presented multiple studies over the weekend demonstrating positive results in metastatic non-small cell lung cancer with its Keytruda immunotherapy.